A RANDOMIZED TRIAL OF CISPLATIN (CACP) + 5-FLUOROURACIL (5-FU) INFUSION AND CACP + 5-FU BOLUS FOR RECURRENT AND ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK

被引：0
|
作者：
KISH, JA
ENSLEY, JF
JACOBS, J
WEAVER, A
CUMMINGS, G
ALSARRAF, M
机构：
[1] WAYNE STATE UNIV,HARPER GRACE HOSP,DIV ONCOL,DETROIT,MI 48201
[2] WAYNE STATE UNIV,HARPER GRACE HOSP,DEPT OTOLARYNGOL,DETROIT,MI 48201
[3] WAYNE STATE UNIV,HARPER GRACE HOSP,DEPT SURG,DETROIT,MI 48201
[4] VET ADM MED CTR,ALLEN PK,MI 48101
来源：
CANCER | 1985年 / 56卷 / 12期
关键词：
D O I：
10.1002/1097-0142(19851215)56:12<2740::AID-CNCR2820561203>3.0.CO;2-Y
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2740 / 2744
页数：5
相关论文
共 50 条
  • [1] A COMPARISON OF CISPLATIN 5-FU WITH CARBOPLATIN 5-FU FOR 5-YEAR SURVIVAL OF PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    EBELING, O
    ECKEL, HE
    VOLLING, P
    HEITMANN, K
    VOSSING, M
    HNO, 1994, 42 (10) : 629 - 635
  • [2] CLINICAL-TRIAL OF CISPLATIN AND 5-FU INFUSION AS INITIAL TREATMENT FOR ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    KISH, J
    DRELICHMAN, A
    JACOBS, J
    HOSCHNER, J
    KINZIE, J
    LOH, J
    WEAVER, A
    ALSARRAF, M
    CANCER TREATMENT REPORTS, 1982, 66 (03): : 471 - 474
  • [3] TREATMENT OF RECURRENT SQUAMOUS-CELL CARCINOMA (RSCCHN) OF HEAD AND NECK WITH A SEQUENTIAL METHOTREXATE (MTX) 5-FLUOROURACIL (5-FU) REGIMEN
    SCHERLACHER, A
    JAKSE, R
    LEHNERT, M
    LARYNGOLOGIE RHINOLOGIE OTOLOGIE VEREINIGT MIT MONATSSCHRIFT FUR OHRENHEILKUNDE, 1985, 64 (02): : 58 - 61
  • [4] COMPARISON OF 5-FLUOROURACIL (5-FU) + CISPLATIN (CISDDPT) WITH 5-FU + CARBOPLATIN (CBDCA) AND 5-FU + IPROPLATIN (CHIP) IN SQUAMOUS-CELL LUNG CA LC-12
    TAPAZOGLOU, E
    CORBETT, T
    POLIN, L
    RATANATHARATHORN, V
    ALSARRAF, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 373 - 373
  • [5] Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2
    Giovanni Mantovani
    Vittorio Gebbia
    Mario Airoldi
    Cesare Bumma
    Paolo Contu
    Alessandro Bianchi
    Massimo Ghiani
    Daniela Dessì
    Elena Massa
    Luigi Curreli
    Biancarosa Lampis
    Paola Lai
    Carlo Mulas
    Antonio Testa
    Ernesto Proto
    Gabrio Cadeddu
    Giorgio Tore
    Cancer Immunology, Immunotherapy, 1998, 47 : 149 - 156
  • [6] Continuous infusion of 5-FU with split-dose cisplatin: An effective treatment for advanced squamous-cell carcinoma of the head and neck
    Luo, Zhiguo
    Chang, Jianhua
    Guo, Ye
    Yu, Hui
    Lu, Fangfang
    Wu, Xianghua
    Li, Jin
    CLINICAL AND INVESTIGATIVE MEDICINE, 2011, 34 (01): : E8 - E13
  • [7] 5-FLUOROURACIL(5-FU) IN PRIMARY TRABECULECTOMY - A RANDOMIZED TRIAL
    LOFTFIELD, K
    BALL, SF
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1991, 32 (04) : 745 - 745
  • [8] CISPLATIN AND 5-FU INFUSIONS IN THERAPY OF ADVANCED SQUAMOUS-CELL CARCINOMA OF HEAD AND NECK IN 50 INDIAN PATIENTS
    SHARMA, SC
    SHARMA, AK
    SINGHAL, KC
    ACTA PHARMACOLOGICA SINICA, 1990, 11 (03): : 288 - 288
  • [9] CDDP AND 5-FU AFTER PRIOR VBM OR VBM AFTER PRIOR CDDP AND 5-FU IN THE MANAGEMENT OF RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    GRIMALDI, A
    MERLANO, M
    GARDIN, G
    ROSSO, R
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (12): : 1539 - 1540
  • [10] A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma
    Ducreux, M
    Rougier, P
    Pignon, JP
    Douillard, JY
    Seitz, JF
    Bugat, R
    Bosset, JF
    Merouche, Y
    Raoul, JL
    Ychou, M
    Adenis, A
    Berthault-Cvitkovic, F
    Luboinski, M
    ANNALS OF ONCOLOGY, 2002, 13 (08) : 1185 - 1191
12345